About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Twitter List
Legislative Tracking Tools
Monthly Archives: August 2009
REMS – A Paper Tiger?
MedGuides are pieces of paper that are shoved into a bag with your prescription to warn a patient about possible side effects. I take some prescriptions myself that come with MedGuides. I never have read one all the way through, … Continue reading
Posted in Risk Management
Comments Off on REMS – A Paper Tiger?
New Offerings by Pharma on YouTube
There has been a slow, but steady march into YouTube-land by pharmaceuticals. Two new companies were added to the growing roster of pharma on YouTube with three new channels added. First – Novartis added a new channel simply called … Continue reading
Posted in New and Social Media
1 Comment
Weekly Roundup – 8/21/09
The ground is baked hard and each day brings a serious threat of thunderstorms. The days are long and humid and the garden has had it. Even the tourists move with a sluggishness that alone indicates that the month in … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup – 8/21/09
Google Wave, Part 2 – What Pharma Should Be Thinking About
Earlier this week, there was a brief overview of what Google Wave is designed to do. Now, let's begin thinking about specific applications for the pharmaceutical industry. Remember, a Wave is a collaborative conversation that will allow multiple forms of … Continue reading
Posted in New and Social Media
8 Comments
Google Wave
As the pharmaceutical industry struggles to find its foothold in social media and regulated by an agency that does not have the appearance of understanding how the Internet is used by patients seeking healthcare information, there is about to be … Continue reading
Posted in New and Social Media
6 Comments